Meiji Holdings Co., Ltd. (2269.T) JPX

Currency In JPY

AD

Meiji Holdings Co., Ltd.

Address

2-4-16, Kyobashi

Tokyo, TY 104-0031

Japan

Phone

81 3 3273 4001

Sector

Consumer Defensive

Industry

Packaged Foods

Employees

17270

First IPO Date

January 04, 2000

Key Executives

NameTitlePayYear Born
Katsunari MatsudaCEO, President & Representative Director108M1957
Bunjiro YaoChief Operating Officer of Food Segment, Executive Officer & Director97M1961
Masashi TanakaGeneral Manager of IR Dept0N/A
Shougo OhishiExecutive Officer & Chief Sustainability Officer01964
Keiko KawahataExecutive Officer of Wellness Science Labs01966
Shinji MatsuokaManaging Executive Officer, CSO & Head of Sustainable Promotion Dept.01960
Toshiaki NagasatoChief Operating Officer of Pharma Segment, Executive Officer & Director01957
Koshi SakamotoGeneral Manager of Intellectual Property Strategy Dept.0N/A
Jun FurutaExecutive Vice President, Chief Digital Officer & Director01957
Jun HishinumaChief Financial Officer, Senior Managing Executive Officer & Director01965
Toshiyasu SekineExecutive Officer & Chief Human Resource Officer01971
AD

Description

Meiji Holdings Co., Ltd., established in Tokyo, Japan, in 1916, operates globally as a prominent manufacturer and seller across two core business segments: Food and Pharmaceutical. Its extensive Food division produces and markets a wide array of products, including various dairy items like yogurts, milk, cheeses, butter, and ice cream. This segment also encompasses a diverse selection of confectioneries, such as chocolates, gummy treats, and candies, alongside nutritional offerings like sports supplements, infant formulas, and beauty aids. Further contributions from the Food sector include frozen foods, sugar, over-the-counter medications, and livestock products, complemented by essential transportation and distribution services. The Pharmaceutical segment is dedicated to the development and provision of human health solutions, specifically targeting infectious diseases and central nervous system disorders, as well as manufacturing generic drugs, human and animal vaccines, and blood plasma products. Additionally, this division supplies a comprehensive range of veterinary medicines for livestock, fisheries, and companion animals, covering antimicrobials, pain relief, anti-inflammatory agents, and specialized treatments, alongside agricultural and livestock chemicals.

AD